Onconetix, Inc. Earnings Per Share (Basic)
Onconetix, Inc. (ONCO) reported Earnings Per Share (Basic) of -$1.28 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Onconetix, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.28.
- Onconetix, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$6.71.
- Onconetix, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $3.61.
- Onconetix, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$6.25.
- Onconetix, Inc. earnings per share, basic for fiscal 2025 was -$16.56.
- Onconetix, Inc. earnings per share, basic for fiscal 2024 was -$1823.39.
- Onconetix, Inc. earnings per share, basic for fiscal 2023 was -$87.45.
- Onconetix, Inc. earnings per share, basic for fiscal 2022 was -$1.10.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.28 10-Q · filed 2026-08-13 | -$6.11 10-Q · filed 2026-08-13 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$6.98 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$6.71 10-Q · filed 2026-05-13 | $1.32 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$6.10 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$11.10 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | $3.61 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$5.84 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$16.56 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | -$6.25 10-Q · filed 2025-11-13 | -$16.21 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$29.14 10-Q · filed 2025-11-13 | -$130.35 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$237.91 10-Q · filed 2026-08-13 | -$4.76 10-Q · filed 2025-08-14 | -$1583.19 10-Q · filed 2026-08-13 | -$31.67 10-Q · filed 2025-08-14 | -$814.94 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1078.44 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||
| 2025-03-31 | -$227.25 10-Q · filed 2026-05-13 | -$0.53 10-Q · filed 2025-06-12 | -$548.64 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$815.63 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$1390.61 derived: net income ÷ weighted average shares · filed 2026-05-13 | |||
| 2024-12-31 | -$294.30 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$576.62 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$1168.90 derived: net income ÷ weighted average shares · filed 2026-03-13 | -$1823.39 10-K · filed 2026-03-13 | -$21.45 10-K · filed 2025-06-02 | |||
| 2024-09-30 | -$249.08 10-Q · filed 2025-11-13 | -$2.93 10-Q · filed 2024-12-10 | -$1656.54 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$3082.12 10-Q · filed 2025-11-13 | -$36.26 10-Q · filed 2024-12-10 | -$196.06 derived: net income ÷ weighted average shares · filed 2025-11-13 | ||
| 2024-06-30 | -$2191.59 10-Q · filed 2025-08-14 | -$0.64 10-Q · filed 2024-08-29 | -$3898.98 10-Q · filed 2025-08-14 | -$1.15 10-Q · filed 2024-08-29 | -$138.16 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$144.02 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||
| 2024-03-31 | -$20.08 10-Q · filed 2025-06-12 | -$0.50 10-Q · filed 2024-05-20 | -$64.93 derived: net income ÷ weighted average shares · filed 2025-06-12 | -$79.27 derived: net income ÷ weighted average shares · filed 2025-06-12 | -$10.52 derived: net income ÷ weighted average shares · filed 2025-06-12 | |||
| 2023-12-31 | -$46.83 derived: net income ÷ weighted average shares · filed 2025-06-02 | -$60.52 derived: net income ÷ weighted average shares · filed 2025-06-02 | -$6.16 derived: net income ÷ weighted average shares · filed 2025-06-02 | -$87.45 10-K · filed 2025-06-02 | -$2.19 10-K · filed 2024-04-11 | |||
| 2023-09-30 | -$12.21 10-Q · filed 2024-12-10 | -$0.31 10-Q · filed 2023-11-17 | -$1.49 derived: net income ÷ weighted average shares · filed 2024-12-10 | -$36.61 10-Q · filed 2024-12-10 | -$0.92 10-Q · filed 2023-11-17 | -$1.51 derived: net income ÷ weighted average shares · filed 2024-12-10 | ||
| 2023-06-30 | -$0.43 10-Q · filed 2024-08-29 | -$0.61 10-Q · filed 2024-08-29 | -$0.81 derived: net income ÷ weighted average shares · filed 2024-08-29 | -$1.08 derived: net income ÷ weighted average shares · filed 2024-08-29 | ||||
| 2023-03-31 | -$0.18 10-Q · filed 2024-05-20 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-05-20 | -$0.64 derived: net income ÷ weighted average shares · filed 2024-05-20 | -$0.97 derived: net income ÷ weighted average shares · filed 2024-05-20 | ||||
| 2022-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-04-11 | -$0.46 derived: net income ÷ weighted average shares · filed 2024-04-11 | -$0.80 derived: net income ÷ weighted average shares · filed 2024-04-11 | -$1.10 10-K · filed 2024-04-11 | ||||
| 2022-09-30 | -$0.27 10-Q · filed 2023-11-17 | -$0.62 derived: net income ÷ weighted average shares · filed 2023-11-17 | -$0.94 10-Q · filed 2023-11-17 | -$1.30 derived: net income ÷ weighted average shares · filed 2023-11-17 | ||||
| 2022-06-30 | -$0.36 10-Q · filed 2023-10-20 | -$0.70 10-Q · filed 2023-10-20 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-10-20 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-10-20 | ||||
| 2022-03-31 | -$0.34 10-Q · filed 2023-05-12 | -$0.74 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$1.13 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$1.44 derived: net income ÷ weighted average shares · filed 2023-05-12 | ||||
| 2021-12-31 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.83 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.12 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.26 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$0.40 10-Q · filed 2022-11-14 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.84 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.29 10-Q · filed 2022-08-15 | -$0.44 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |